Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease
Rachel Kelly, Valerie Joers, Malú G. Tansey, et al.
Molecules (2020) Vol. 25, Iss. 3, pp. 453-453
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage
José A. Fernández‐Albarral, Ana I. Ramı́rez, Rosa de Hoz, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 22
Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review
Ruwini Cooray, Veer Bala Gupta, Cenk Suphioglu
Molecular Neurobiology (2020) Vol. 57, Iss. 11, pp. 4878-4890
Open Access | Times Cited: 112
Drp1 and neuroinflammation: Deciphering the interplay between mitochondrial dynamics imbalance and inflammation in neurodegenerative diseases
Peiyang Cai, Wuhao Li, Ye Xu, et al.
Neurobiology of Disease (2024) Vol. 198, pp. 106561-106561
Open Access | Times Cited: 9
Glutaminase in microglia: A novel regulator of neuroinflammation
Lu Ding, Xiaonan Xu, Congcong Li, et al.
Brain Behavior and Immunity (2020) Vol. 92, pp. 139-156
Open Access | Times Cited: 58
Opposing functions of β-arrestin 1 and 2 in Parkinson’s disease via microglia inflammation and Nprl3
Yinquan Fang, Qingling Jiang, Shanshan Li, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 6, pp. 1822-1836
Open Access | Times Cited: 43
Deficiency in endocannabinoid synthase DAGLB contributes to early onset Parkinsonism and murine nigral dopaminergic neuron dysfunction
Zhenhua Liu, Nannan Yang, Jie Dong, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
Towards PET imaging of the dynamic phenotypes of microglia
Wissam Beaino, Bieneke Janssen, Daniëlle J. Vugts, et al.
Clinical & Experimental Immunology (2021) Vol. 206, Iss. 3, pp. 282-300
Open Access | Times Cited: 40
The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
Gerwyn Morris, Ken Walder, Stefan Kloiber, et al.
Pharmacological Research (2021) Vol. 170, pp. 105729-105729
Closed Access | Times Cited: 33
Curcumin protects against rotenone-induced Parkinson's disease in mice by inhibiting microglial NLRP3 inflammasome activation and alleviating mitochondrial dysfunction
Long Xu, Liping Hao, Jing Yu, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e16195-e16195
Open Access | Times Cited: 14
Cannabinoid CB2 receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice
Hai‐Ying Zhang, Hui Shen, Ming Gao, et al.
Neuropharmacology (2021) Vol. 189, pp. 108538-108538
Open Access | Times Cited: 27
Research progress on the cannabinoid type-2 receptor and Parkinson’s disease
Xiao‐Qi Yu, Yi Jia, Yuan Dong
Frontiers in Aging Neuroscience (2024) Vol. 15
Open Access | Times Cited: 4
Molecular Mechanisms Underlying Neuroinflammation Intervention with Medicinal Plants: A Critical and Narrative Review of the Current Literature
Sandra Maria Barbalho, Beatriz Leme Boaro, Jéssica da Silva Camarinha Oliveira, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 133-133
Open Access
Alcohol and Cannabis Use for Pain Management: Translational Findings of Relative Risks, Benefits, and Interactions
Sumin Lee, Scott Edwards
Physiology & Behavior (2025), pp. 114867-114867
Closed Access
Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story
Emilia Carbone, Antonia Manduca, Claudia Cacchione, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 121, pp. 128-143
Closed Access | Times Cited: 29
Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?
Tomasz Charytoniuk, Hubert Żywno, Karolina Konstantynowicz-Nowicka, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4221-4221
Open Access | Times Cited: 28
Targeting the inflammasome in Parkinson’s disease
Qi Su, Wei Lun Ng, Suh Yee Goh, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 16
Neuroinflammation in the Central Nervous System: Exploring the Evolving Influence of Endocannabinoid System
Sumit Rathod, Yogeeta O. Agrawal, Kartik T. Nakhate, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2642-2642
Open Access | Times Cited: 10
Role of cannabinoids in alcohol-induced neuroinflammation
Alba García-Baos, Laia Alegre-Zurano, Lídia Cantacorps, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 104, pp. 110054-110054
Open Access | Times Cited: 27
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
Barbara Vuić, Tina Milos, Lucija Tudor, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3000-3000
Open Access | Times Cited: 14
Alpha-Synuclein: The Interplay of Pathology, Neuroinflammation, and Environmental Factors in Parkinson’s Disease
Songzhe He, Shan Zhong, Gang Liu, et al.
Neurodegenerative Diseases (2020) Vol. 20, Iss. 2-3, pp. 55-64
Open Access | Times Cited: 23
Cannabinoids: Potential for Modulation and Enhancement When Combined with Vitamin B12 in Case of Neurodegenerative Disorders
Anna Aleksandra Kaszyńska
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 813-813
Open Access | Times Cited: 2
The CB2 cannabinoid receptor as a therapeutic target in the central nervous system
David Cabañero, Elena Martín‐García, Rafaël Maldonado
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 8, pp. 659-676
Closed Access | Times Cited: 16
Positron Emission Tomography of Neuroimmune Responses in Humans: Insights and Intricacies
Nakul Ravi Raval, Reagan R. Wetherill, Corinde E. Wiers, et al.
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 2, pp. 213-229
Open Access | Times Cited: 12
Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy
Valerie Joers, Benjamin Murray, Caroline McLaughlin, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Time-Course of Alterations in the Endocannabinoid System after Viral-Mediated Overexpression of α-Synuclein in the Rat Brain
Rachel Kelly, Alexis‐Pierre Bemelmans, Charlène Joséphine, et al.
Molecules (2022) Vol. 27, Iss. 2, pp. 507-507
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top